Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Elymoclavine Hydrochloride
2. Elymoklavine
1. 548-43-6
2. 8,9-didehydro-6-methylergoline-8-methanol
3. 5lr46dlo0d
4. Elimoclavin
5. ((6ar,10ar)-7-methyl-4,6,6a,7,8,10a-hexahydroindolo[4,3-fg]quinolin-9-yl)methanol
6. [(6ar,10ar)-7-methyl-6,6a,8,10a-tetrahydro-4h-indolo[4,3-fg]quinolin-9-yl]methanol
7. Spectrum5_001634
8. Unii-5lr46dlo0d
9. Nsc-109431
10. Einecs 208-948-9
11. Nsc 109431
12. Brn 0030650
13. Elymoclavine [mi]
14. 4-23-00-02716 (beilstein Handbook Reference)
15. Schembl183704
16. Spectrum1800052
17. Chebi:4777
18. Chembl3706997
19. Dtxsid70970145
20. Zinc896007
21. C06068
22. Methanol, (8,9-didehydro-6-methylergolin-8-yl)-
23. Q5368476
24. [(2r,7r)-6-methyl-6,11-diazatetracyclo[7.6.1.0?,?.0??,??]hexadeca-1(16),3,9,12,14-pentaen-4-yl]methanol
| Molecular Weight | 254.33 g/mol |
|---|---|
| Molecular Formula | C16H18N2O |
| XLogP3 | 1.3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 1 |
| Exact Mass | 254.141913202 g/mol |
| Monoisotopic Mass | 254.141913202 g/mol |
| Topological Polar Surface Area | 39.3 Ų |
| Heavy Atom Count | 19 |
| Formal Charge | 0 |
| Complexity | 394 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Elymoclavine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Elymoclavine, including repackagers and relabelers. The FDA regulates Elymoclavine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Elymoclavine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Elymoclavine supplier is an individual or a company that provides Elymoclavine active pharmaceutical ingredient (API) or Elymoclavine finished formulations upon request. The Elymoclavine suppliers may include Elymoclavine API manufacturers, exporters, distributors and traders.
click here to find a list of Elymoclavine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Elymoclavine DMF (Drug Master File) is a document detailing the whole manufacturing process of Elymoclavine active pharmaceutical ingredient (API) in detail. Different forms of Elymoclavine DMFs exist exist since differing nations have different regulations, such as Elymoclavine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Elymoclavine DMF submitted to regulatory agencies in the US is known as a USDMF. Elymoclavine USDMF includes data on Elymoclavine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Elymoclavine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Elymoclavine suppliers with USDMF on PharmaCompass.
Elymoclavine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Elymoclavine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Elymoclavine GMP manufacturer or Elymoclavine GMP API supplier for your needs.
A Elymoclavine CoA (Certificate of Analysis) is a formal document that attests to Elymoclavine's compliance with Elymoclavine specifications and serves as a tool for batch-level quality control.
Elymoclavine CoA mostly includes findings from lab analyses of a specific batch. For each Elymoclavine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Elymoclavine may be tested according to a variety of international standards, such as European Pharmacopoeia (Elymoclavine EP), Elymoclavine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Elymoclavine USP).
LOOKING FOR A SUPPLIER?
